Colonics
About Me
Recent Posts
- 4 Mushroom Poisonings In 2 Weeks - Doctors Test Milk Thistle As Treatment
- Improved Diagnostics For Sleeping Sickness
- Prostate Growth May Be Slowed By Statins
- New Tools For Psychological Science Research - Facebook And Smartphones
- Finding That Oxytocin Improves Brain Function In Children With Autism Could Lead To Treatment For Associated Social Deficits
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
Friends
Links
Entry 1 of 2380
Last Page | Next Page
10/20/2009
-
Positive data from BioSante Pharmaceuticals' LibiGel Phase III clinical development program
|
BioSante Pharmaceuticals, Inc., today announced total safety data in its ongoing LibiGel Phase III clinical evolution program. For the first time, unblinded data have been reviewed by the unconstrained DMC of the LibiGel shape and Breast Cancer Safety Study. Based on this review of unblinded data, the DMC unanimously food pyramid continuation of the study as described in the study protocol, with no modifications. More: - Read the rest here |
Post A Comment! :: Send to a Friend! |
Share and enjoy
